These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 18078017

  • 1. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
    Poon MC.
    Vasc Health Risk Manag; 2007; 3(5):655-64. PubMed ID: 18078017
    [Abstract] [Full Text] [Related]

  • 2. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC.
    Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
    [Abstract] [Full Text] [Related]

  • 3. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC, Di Minno G, d'Oiron R, Zotz R.
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [Abstract] [Full Text] [Related]

  • 4. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 5. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
    Rajpurkar M, Chitlur M, Recht M, Cooper DL.
    Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404
    [Abstract] [Full Text] [Related]

  • 6. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M, Lippi G.
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
    Poon MC, D'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M, International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group.
    J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
    [Abstract] [Full Text] [Related]

  • 8. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
    Recht M, Rajpurkar M, Chitlur M, d'Oiron R, Zotz R, Di Minno G, Cooper DL, Poon MC.
    Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
    [Abstract] [Full Text] [Related]

  • 9. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T.
    Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
    [Abstract] [Full Text] [Related]

  • 10. The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders.
    Poon MC.
    Transfus Med Rev; 2007 Jul; 21(3):223-36. PubMed ID: 17572261
    [Abstract] [Full Text] [Related]

  • 11. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

  • 12. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T.
    J Ayub Med Coll Abbottabad; 2009 Jun; 21(2):171-3. PubMed ID: 20524499
    [Abstract] [Full Text] [Related]

  • 13. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
    d'Oiron R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Négrier C.
    Thromb Haemost; 2000 May; 83(5):644-7. PubMed ID: 10823254
    [Abstract] [Full Text] [Related]

  • 14. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A.
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
    [Abstract] [Full Text] [Related]

  • 15. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
    Poon MC, Demers C, Jobin F, Wu JW.
    Blood; 1999 Dec 01; 94(11):3951-3. PubMed ID: 10572113
    [Abstract] [Full Text] [Related]

  • 16. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y.
    Pathophysiol Haemost Thromb; 2002 Dec 01; 32 Suppl 1():37-40. PubMed ID: 12214146
    [Abstract] [Full Text] [Related]

  • 17. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN, Saylan S, Cekic B.
    Rev Bras Anestesiol; 2012 Jul 01; 62(4):548-53. PubMed ID: 22793971
    [Abstract] [Full Text] [Related]

  • 18. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
    Erduran E, Aksoy A, Zaman D.
    Blood Coagul Fibrinolysis; 2009 Apr 01; 20(3):215-7. PubMed ID: 19657319
    [Abstract] [Full Text] [Related]

  • 19. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC, d'Oiron R, Zotz RB, Bindslev N, Di Minno MN, Di Minno G, Glanzmann Thrombasthenia Registry Investigators.
    Haematologica; 2015 Aug 01; 100(8):1038-44. PubMed ID: 26001792
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.